• Kim Tae Hun disclosed ownership of 130 Samyang Biopharm common shares as of Nov. 4, 2026.
• His appointment as an unregistered executive on Nov. 1, 2026, triggered the initial shareholding disclosure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samyang Biopharm Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105000557), on November 05, 2026, and is solely responsible for the information contained therein.